title: Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors.
abstract: Recruitment of monocytes into sites of inflammation is essential in the immune response. In cancer, recruited monocytes promote invasion, metastasis, and possibly angiogenesis. LDL receptor-related protein (LRP1) is an endocytic and cell-signaling receptor that regulates cell migration. In this study, we isografted PanO2 pancreatic carcinoma cells into mice in which LRP1 was deleted in myeloid lineage cells. Recruitment of monocytes into orthotopic and subcutaneous tumors was significantly increased in these mice, compared with control mice. LRP1-deficient bone marrow-derived macrophages (BMDM) expressed higher levels of multiple chemokines, including, most prominently, macrophage inflammatory protein-1α/CCL3, which is known to amplify inflammation. Increased levels of CCL3 were detected in LRP1-deficient tumor-associated macrophages (TAM), isolated from PanO2 tumors, and in RAW 264.7 macrophage-like cells in which LRP1 was silenced. LRP1-deficient BMDMs migrated more rapidly than LRP1-expressing cells in vitro. The difference in migration was reversed by CCL3-neutralizing antibody, by CCR5-neutralizing antibody, and by inhibiting NF-κB with JSH-23. Inhibiting NF-κB reversed the increase in CCL3 expression associated with LRP1 gene silencing in RAW 264.7 cells. Tumors formed in mice with LRP1-deficient myeloid cells showed increased angiogenesis. Although VEGF mRNA expression was not increased in LRP1-deficient TAMs, at the single-cell level, the increase in TAM density in tumors with LRP1-deficient myeloid cells may have allowed these TAMs to contribute an increased amount of VEGF to the tumor microenvironment. Our results show that macrophage density in tumors is correlated with cancer angiogenesis in a novel model system. Myeloid cell LRP1 may be an important regulator of cancer progression.
authors: Department of Pathology, University of California San Diego School of Medicine, La Jolla, California, USA.
authors: Nicole D
authors: ND
authors: Staudt
authors: Minji
authors: M
authors: Jo
authors: Jingjing
authors: J
authors: Hu
authors: Jeanne M
authors: JM
authors: Bristow
authors: Donald P
authors: DP
authors: Pizzo
authors: Alban
authors: A
authors: Gaultier
authors: Scott R
authors: SR
authors: VandenBerg
authors: Steven L
authors: SL
authors: Gonias
mesh_terms: D000818:Animals; D002460:Cell Line; D002465:Cell Movement; D054405:Chemokine CCL3 / Q000235:genetics / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009000:Monocytes / Q000276:immunology* / Q000378:metabolism; D022423:Myeloid Cells; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000098:blood supply* / Q000276:immunology; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D019713:Receptors, CCR5 / Q000235:genetics / Q000378:metabolism; D011973:Receptors, LDL / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D025521:Tumor Suppressor Proteins / Q000172:deficiency* / Q000235:genetics / Q000502:physiology
chemical_list: C496534:Ccl3 protein, mouse; D054405:Chemokine CCL3; D026503:Low Density Lipoprotein Receptor-Related Protein-1; C486645:Lrp1 protein, mouse; D019713:Receptors, CCR5; D011973:Receptors, LDL; D025521:Tumor Suppressor Proteins
references: J Leukoc Biol. 1996 Jan;59(1):61-6
references: 8558069
references: J Cell Biochem. 2009 Feb 15;106(3):372-80
references: 19115269
references: J Biol Chem. 2013 Jan 4;288(1):123-31
references: 23105102
references: Blood. 2012 Oct 18;120(16):3280-7
references: 22948049
references: Nat Rev Immunol. 2011 Oct 14;11(11):723-37
references: 21997792
references: J Biol Chem. 1997 May 30;272(22):14372-9
references: 9162074
references: J Cell Biol. 2002 Dec 23;159(6):1061-70
references: 12499359
references: J Leukoc Biol. 2010 Oct;88(4):769-78
references: 20610799
references: Circ Res. 2007 Mar 16;100(5):670-7
references: 17303763
references: PLoS One. 2011;6(12):e28846
references: 22174911
references: Cancer Metastasis Rev. 2011 Mar;30(1):83-95
references: 21249423
references: Thromb Haemost. 2004 Jun;91(6):1056-64
references: 15175790
references: Blood. 2008 Jun 1;111(11):5316-25
references: 18369152
references: Nat Rev Immunol. 2011 Oct 10;11(11):762-74
references: 21984070
references: J Immunol. 2001 Jun 15;166(12):7353-61
references: 11390486
references: Cell. 2010 Apr 2;141(1):39-51
references: 20371344
references: Biochem Biophys Res Commun. 2012 Jan 27;417(4):1304-9
references: 22234309
references: J Biol Chem. 2012 Oct 19;287(43):36593-608
references: 22927430
references: Med Oncol. 2012 Dec;29(4):2317-22
references: 22198695
references: Am J Pathol. 2011 Sep;179(3):1157-70
references: 21771572
references: Cancer Res. 2009 Oct 1;69(19):7884-92
references: 19773434
references: J Biol Chem. 2002 Apr 5;277(14):11772-9
references: 11729193
references: Nat Rev Immunol. 2005 Oct;5(10):749-59
references: 16175180
references: J Biol Chem. 2010 May 7;285(19):14259-66
references: 20197276
references: Cancer Res. 1996 Oct 15;56(20):4625-9
references: 8840975
references: J Biol Chem. 1990 Nov 15;265(32):19441-6
references: 1700978
references: J Surg Res. 2011 May 15;167(2):e211-9
references: 19765725
references: Med Oncol. 2011 Dec;28(4):1447-52
references: 20676804
references: J Cell Sci. 2009 Apr 15;122(Pt 8):1155-62
references: 19299462
references: J Biol Chem. 1996 Oct 4;271(40):24894-900
references: 8798766
references: J Clin Invest. 1998 Feb 1;101(3):689-95
references: 9449704
references: Int J Biochem Cell Biol. 2004 Oct;36(10):1882-6
references: 15203102
references: Nature. 2002 Dec 19-26;420(6917):860-7
references: 12490959
references: J Mammary Gland Biol Neoplasia. 2002 Apr;7(2):177-89
references: 12463738
references: J Cell Biochem. 2008 Aug 1;104(5):1587-97
references: 18646053
references: Cell. 1992 Oct 30;71(3):411-21
references: 1423604
references: Trends Endocrinol Metab. 2002 Mar;13(2):66-74
references: 11854021
references: Cytokine. 2012 Aug;59(2):423-32
references: 22617682
references: EMBO J. 2006 May 3;25(9):1860-70
references: 16601674
references: Atherosclerosis. 2013 Mar;227(1):79-88
references: 23312784
references: Int J Dev Biol. 2011;55(7-9):861-7
references: 22161841
references: J Mol Diagn. 2012 Jan;14(1):22-9
references: 22166544
references: J Clin Invest. 1993 Mar;91(3):1219-24
references: 7680664
references: Curr Opin Immunol. 2010 Apr;22(2):231-7
references: 20144856
references: J Leukoc Biol. 1996 May;59(5):733-9
references: 8656060
references: Sci STKE. 2003 Apr 01;2003(176):PE12
references: 12671190
references: Biochem Pharmacol. 1991 Feb 1;41(3):333-7
references: 1994892